Further evidence for a link between melarsoprol resistance and P2 transporter function in African trypanosomes

Molecular and Biochemical Parasitology

Volumn 106, Issue 1, 2000, Pages 181-185

  De Koning, Harry P ^a   MacLeod, Annette ^b   Barrett, Michael P ^b   Cover, Brian ^a   Jarvis, Simon M ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Arsenicals; Drug resistance; Purine transport; Trypanosoma brucei

Indexed keywords

DNA MINISATELLITE; INOSINE; MELARSOPROL; PENTAMIDINE; PURINE P2 RECEPTOR; SURAMIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CROSS RESISTANCE; CYTOLYSIS; DRUG UPTAKE; GENE AMPLIFICATION; GENE FUNCTION; GENE MUTATION; MITOSIS; NONHUMAN; PRIORITY JOURNAL; TRYPANOSOMA BRUCEI;

ANIMALS; ANTIPROTOZOAL AGENTS; ARSENICALS; BIOLOGICAL TRANSPORT, ACTIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; MELARSOPROL; MICE; MICE, INBRED BALB C; MINISATELLITE REPEATS; PURINES; TRYPANOCIDAL AGENTS; TRYPANOSOMA BRUCEI BRUCEI;

EID: 0033965784     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(99)00206-6     Document Type: Article

References (14)

1. Carter N.S., Fairlamb A.H. Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature. 361:1993;173-175.
2. Fairlamb A.H., Carter N.S., Cunningham M., Smith K. Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism. Mol. Biochem. Parasitol. 53:1992;213-222.
3. Carter N.S., Berger B.J., Fairlamb A.H. Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei. J. Biol. Chem. 270:1995;28153-28157.
4. Barrett M.P., Zhang Z.Q., Denise H., Giroud C., Baltz T. A diamidine-resistant Trypanosoma equiperdum clone contains a P2 purine transporter with reduced substrate affinity. Mol. Biochem. Parasitol. 73:1995;223-229.
5. Ross C.A., Barns A.M. Alteration to one of three adenosine transporters is associated with resistance to Cymelarsan in Trypanosoma evansi. Parasitol. Res. 82:1996;183-188.
6. Mäser P., Sütterlin C., Kralli A., Kaminsky R. A nucleoside transporter from Trypanosoma brucei involved in drug resistance. Science. 285:1999;242-244.
7. Barrett M.P., MacLeod A., Tovar J., Sweetman J.P., Tait A., Le Page R.W.F., Melville S.E. A single locus minisatellite sequence which distinguishes between Trypanosoma brucei isolates. Mol. Biochem. Parasitol. 86:1997;95-99.
8. Fairlamb A.H., Smith K., Hunter K.J. The interaction of arsenical drugs with dihydrolipoamide and dihydrolipoamide dehydrogenase from arsenical resistant and sensitive strains of Trypanosoma brucei brucei. Mol. Biochem. Parasitol. 53:1992;223-232.
9. Hei T.K., Liu S.X., Waldren C. Mutagenicity of arsenicals in mammalian cells: roles of reactive oxygen species. Proc. Natl. Acad. Sci. USA. 95:1998;8103-8107.
10. Barrett M.P. The fall and rise of sleeping sickness. Lancet. 353:1999;1113-1114.
11. Tye K., Kasinathan G., Barrett M.P., Doyle P., Fairlamb A.H., Weaver R., Gilbert I.H. An approach to use an unusual adenosine transporter to selectively deliver polyamine analogues to trypanosomes. Biorg. Med. Chem. Lett. 8:1998;811-816.
12. De Koning H.P., Watson C.J., Jarvis S.M. Characterisation of a nucleoside/proton symporter in procyclic Trypanosoma brucei brucei. J. Biol. Chem. 273:1998;9486-9494.
13. De Koning H.P., Jarvis S.M. Purine nucleobase transport in bloodstream forms of Trypanosoma brucei brucei is mediated by two novel transporters. Mol. Biochem. Parasitol. 89:1997;245-258.
14. Berger B.J., Carter N.S., Fairlamb A.H. Characterisation of pentamidine-resistant Trypanosoma brucei brucei. Mol. Biochem. Parasitol. 69:1995;289-298.